HEPARIN RECALLS

On March 20, 2008, American Health Packaging, a subsidiary of AmerisourceBergen Corporation, began recalling 1,421 units of 10000 USP units/mL heparin sodium injection 1 mL vials.  The vials were manufactured by Baxter and then placed by American Health Packaging into individually labeled bags for use in pharmacy automation equipment.
 
On March 21, 2008, B. Braun Medical, Inc. began recalling 23 lots of its heparin products because of a notification it received from Scientific Protein Laboratories (SPL) that one lot of the active pharmaceutical ingredient that Scientific Protein Laboratories sold to B. Braun Medical, Inc. was contaminated with the heparin-like contaminant.

On March 28, 2008, Covidien began recalling 32 lots of its heparin products because of a notification it received from SPL of a nationwide recall of Heparin Sodium USP.  The active pharmaceutical ingredient (API) in heparin has been produced in SPL’s Chinese plant since 2004.

Return to Main Article